Mircera User Reviews & Ratings
Mircera has an average rating of 2.0 out of 10 from a total of 4 reviews on Drugs.com. 0% of reviewers reported a positive experience, while 67% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Anemia Due to Chronic Kidney Disease | 4 reviews for Anemia Due to Chronic Kidney Disease | 66 medications |
- Joe...
- Taken for 6 months to 1 year
- March 23, 2018
For Anemia Due to Chronic Kidney Disease "I have been on this drug for a year. Used to take EPO for the previous 20 years. Never had a single blood transfusion until I started Mircera about a year ago. Since I started Mircera, I have had 7 blood transfusions and am scheduled for another unit tomorrow. My hemoglobin has never reached an 8 while using Mircera. My medical care is insisting I use this 'cheaper' than EPO drug. You know, since money in investor pockets matters more than any patient's quality of life. I may have to get an attorney to get my medical care to pull their head in. For those that don't know and are having issues on Mircera, other dialysis doesn't give Mircera. Mircera is worse."
- Ran...
- Taken for 1 to 6 months
- September 10, 2018
For Anemia Due to Chronic Kidney Disease "I was on Procrit for the six months prior to dialysis. My hemoglobin rate had dropped below 9. The Procrit would usually bring the level to about 10. When dialysis was begun, I was changed to Mircera. Since that time, my hemoglobin rate has never once climbed above 8, and I am always weak and tired."
- Pea...
- June 19, 2019
For Anemia Due to Chronic Kidney Disease "Not good to use. I’m weaker after the Mircera shot."
More about Mircera (epoetin beta-methoxy polyethylene glycol)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: recombinant human erythropoietins
- Breastfeeding
- En español
For Anemia Due to Chronic Kidney Disease "This drug is being given to my husband during dialysis, as he currently has acute kidney injury (AKI) and end-stage renal disease (ESRD) due to multiple myeloma. Additionally, he is undergoing chemotherapy. He is constantly feeling tired now, whereas he was not as fatigued when he was on Epo. He was switched to this drug only a few weeks ago, and since then, his hemoglobin levels have been decreasing. A significant drop occurred a few days ago. Our main concern is that his nephrologists and the dialysis center perceive themselves as the most important entity in his care, without sharing information with other doctors he sees. None of his other 14 providers were aware that he was taking this medication, which is clearly contraindicated with chemotherapy. I will switch him back to Epo as soon as I can convince the doctor that he should not be taking this medication."